北京百普赛斯生物科技股份有限公司2025年半年度报告摘要

Group 1 - The company does not plan to distribute cash dividends, issue bonus shares, or increase capital from reserves during the reporting period [2] - The company has undergone retrospective adjustments or restatements of previous accounting data due to other reasons [2] - There has been no change in the controlling shareholder during the reporting period [3] Group 2 - There has been no change in the actual controller during the reporting period [4] - There are no preferred shareholders or related holdings reported during the reporting period [4] - There are no significant matters reported in the half-year report [4]